<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
  <title>Nuclide readout calendar</title>
  <subtitle>Regulatory dates, advisory committees, expected trial readouts and congresses. Expected dates are editorial estimates until confirmed.</subtitle>
  <link rel="self" type="application/atom+xml" href="https://nuclide.cc/feeds/calendar.xml"/>
  <link rel="alternate" type="text/html" href="https://nuclide.cc/calendar/"/>
  <id>https://nuclide.cc/feeds/calendar.xml</id>
  <updated>2027-11-11T00:00:00Z</updated>
  <author><name>Nuclide</name><uri>https://nuclide.cc/</uri></author>
  <rights>Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)"; commercial use needs a licence</rights>
  <generator uri="https://github.com/casadesante/Nuclide">Nuclide build-feeds</generator>
  <entry>
    <title>2026-10-17: EANM'26, 39th Annual Congress of the European Association of Nuclear Medicine, Vienna (17 to 21 October)</title>
    <link rel="alternate" href="https://nuclide.cc/calendar/"/>
    <link rel="related" href="https://eanm.org/congress-scientific-events/eanm26/"/>
    <link rel="related" href="https://nuclide.cc/institutions/eanm/"/>
    <link rel="related" href="https://nuclide.cc/technologies/prrt/"/>
    <link rel="related" href="https://nuclide.cc/technologies/lu177-radioligand-therapy/"/>
    <link rel="related" href="https://nuclide.cc/technologies/radioligand-dosimetry/"/>
    <id>https://nuclide.cc/calendar/#2026-10-17-eanm-26-39th-annual-congress-of-the-european-association-of-</id>
    <updated>2026-10-17T00:00:00Z</updated>
    <summary type="text">Congress. Europe's largest nuclear medicine congress, with dedicated radiopharmacy, dosimetry and theranostics tracks. European first-in-human radioligand data and the EANM guideline updates land here.</summary>
    <content type="html">&lt;p&gt;&lt;strong&gt;Congress&lt;/strong&gt;, confirmed.&lt;/p&gt;&lt;p&gt;Europe's largest nuclear medicine congress, with dedicated radiopharmacy, dosimetry and theranostics tracks. European first-in-human radioligand data and the EANM guideline updates land here.&lt;/p&gt;&lt;p&gt;Related: &lt;a href=&quot;https://nuclide.cc/institutions/eanm/&quot;&gt;European Association of Nuclear Medicine&lt;/a&gt;, &lt;a href=&quot;https://nuclide.cc/technologies/prrt/&quot;&gt;Peptide receptor radionuclide therapy (PRRT)&lt;/a&gt;, &lt;a href=&quot;https://nuclide.cc/technologies/lu177-radioligand-therapy/&quot;&gt;Lutetium-177 radioligand therapy&lt;/a&gt;, &lt;a href=&quot;https://nuclide.cc/technologies/radioligand-dosimetry/&quot;&gt;Radioligand dosimetry&lt;/a&gt;&lt;/p&gt;&lt;p&gt;Source: &lt;a href=&quot;https://eanm.org/congress-scientific-events/eanm26/&quot;&gt;https://eanm.org/congress-scientific-events/eanm26/&lt;/a&gt;&lt;/p&gt;</content>
  </entry>
  <entry>
    <title>2026-11-04: SNMMI Theranostics Conference 2026, Bethesda, Maryland (4 to 7 November)</title>
    <link rel="alternate" href="https://nuclide.cc/calendar/"/>
    <link rel="related" href="https://snmmi.org/Theranostics/"/>
    <link rel="related" href="https://nuclide.cc/institutions/snmmi/"/>
    <link rel="related" href="https://nuclide.cc/technologies/radioligand-therapy/"/>
    <link rel="related" href="https://nuclide.cc/technologies/radioligand-dosimetry/"/>
    <link rel="related" href="https://nuclide.cc/technologies/lu177-radioligand-therapy/"/>
    <id>https://nuclide.cc/calendar/#2026-11-04-snmmi-theranostics-conference-2026-bethesda-maryland-4-to-7-</id>
    <updated>2026-11-04T00:00:00Z</updated>
    <summary type="text">Congress. SNMMI's conference devoted to theranostics alone: dosimetry practice, alpha-emitter programmes, supply and reimbursement rather than broad nuclear medicine.</summary>
    <content type="html">&lt;p&gt;&lt;strong&gt;Congress&lt;/strong&gt;, confirmed.&lt;/p&gt;&lt;p&gt;SNMMI's conference devoted to theranostics alone: dosimetry practice, alpha-emitter programmes, supply and reimbursement rather than broad nuclear medicine.&lt;/p&gt;&lt;p&gt;Related: &lt;a href=&quot;https://nuclide.cc/institutions/snmmi/&quot;&gt;Society of Nuclear Medicine and Molecular Imaging&lt;/a&gt;, &lt;a href=&quot;https://nuclide.cc/technologies/radioligand-therapy/&quot;&gt;Radioligand therapy (beta emitters)&lt;/a&gt;, &lt;a href=&quot;https://nuclide.cc/technologies/radioligand-dosimetry/&quot;&gt;Radioligand dosimetry&lt;/a&gt;, &lt;a href=&quot;https://nuclide.cc/technologies/lu177-radioligand-therapy/&quot;&gt;Lutetium-177 radioligand therapy&lt;/a&gt;&lt;/p&gt;&lt;p&gt;Source: &lt;a href=&quot;https://snmmi.org/Theranostics/&quot;&gt;https://snmmi.org/Theranostics/&lt;/a&gt;&lt;/p&gt;</content>
  </entry>
  <entry>
    <title>2026-11-06: 65th Annual Meeting of the Korean Society of Nuclear Medicine with the 25th ARCCNM, Seoul (6 to 7 November)</title>
    <link rel="alternate" href="https://nuclide.cc/calendar/"/>
    <link rel="related" href="https://www.ksnm.or.kr/eng/"/>
    <link rel="related" href="https://nuclide.cc/institutions/ksnm/"/>
    <link rel="related" href="https://nuclide.cc/companies/futurechem/"/>
    <link rel="related" href="https://nuclide.cc/companies/cellbion/"/>
    <id>https://nuclide.cc/calendar/#2026-11-06-65th-annual-meeting-of-the-korean-society-of-nuclear-medicin</id>
    <updated>2026-11-06T00:00:00Z</updated>
    <summary type="text">Congress. Korea's national nuclear medicine meeting, held with the Asian Regional Cooperative Council for Nuclear Medicine. Where Korean radioligand programmes (FutureChem, CellBion) report domestically before Western congresses.</summary>
    <content type="html">&lt;p&gt;&lt;strong&gt;Congress&lt;/strong&gt;, confirmed.&lt;/p&gt;&lt;p&gt;Korea's national nuclear medicine meeting, held with the Asian Regional Cooperative Council for Nuclear Medicine. Where Korean radioligand programmes (FutureChem, CellBion) report domestically before Western congresses.&lt;/p&gt;&lt;p&gt;Related: &lt;a href=&quot;https://nuclide.cc/institutions/ksnm/&quot;&gt;Korean Society of Nuclear Medicine&lt;/a&gt;, &lt;a href=&quot;https://nuclide.cc/companies/futurechem/&quot;&gt;FutureChem&lt;/a&gt;, &lt;a href=&quot;https://nuclide.cc/companies/cellbion/&quot;&gt;CellBion&lt;/a&gt;&lt;/p&gt;&lt;p&gt;Source: &lt;a href=&quot;https://www.ksnm.or.kr/eng/&quot;&gt;https://www.ksnm.or.kr/eng/&lt;/a&gt;&lt;/p&gt;</content>
  </entry>
  <entry>
    <title>2026-11-19: 66th Annual Scientific Meeting of the Japanese Society of Nuclear Medicine, Himeji (19 to 21 November)</title>
    <link rel="alternate" href="https://nuclide.cc/calendar/"/>
    <link rel="related" href="https://jsnm.org/english/meetings_and_events/"/>
    <link rel="related" href="https://nuclide.cc/institutions/jsnm/"/>
    <link rel="related" href="https://nuclide.cc/companies/pdradiopharma/"/>
    <link rel="related" href="https://nuclide.cc/companies/nihon-medi-physics/"/>
    <id>https://nuclide.cc/calendar/#2026-11-19-66th-annual-scientific-meeting-of-the-japanese-society-of-nu</id>
    <updated>2026-11-19T00:00:00Z</updated>
    <summary type="text">Congress. Japan's national nuclear medicine meeting. Japanese approvals and supply questions (domestic Mo-99 production, PDRadiopharma's product line) are discussed here first.</summary>
    <content type="html">&lt;p&gt;&lt;strong&gt;Congress&lt;/strong&gt;, confirmed.&lt;/p&gt;&lt;p&gt;Japan's national nuclear medicine meeting. Japanese approvals and supply questions (domestic Mo-99 production, PDRadiopharma's product line) are discussed here first.&lt;/p&gt;&lt;p&gt;Related: &lt;a href=&quot;https://nuclide.cc/institutions/jsnm/&quot;&gt;Japanese Society of Nuclear Medicine&lt;/a&gt;, &lt;a href=&quot;https://nuclide.cc/companies/pdradiopharma/&quot;&gt;PDRadiopharma&lt;/a&gt;, &lt;a href=&quot;https://nuclide.cc/companies/nihon-medi-physics/&quot;&gt;Nihon Medi-Physics&lt;/a&gt;&lt;/p&gt;&lt;p&gt;Source: &lt;a href=&quot;https://jsnm.org/english/meetings_and_events/&quot;&gt;https://jsnm.org/english/meetings_and_events/&lt;/a&gt;&lt;/p&gt;</content>
  </entry>
  <entry>
    <title>2027-02-04: SNMMI Mid-Winter Meeting 2027, San Francisco (4 to 6 February)</title>
    <link rel="alternate" href="https://nuclide.cc/calendar/"/>
    <link rel="related" href="https://snmmi.org/AM/Web/Education-and-Meetings/Upcoming-Events.aspx"/>
    <link rel="related" href="https://nuclide.cc/institutions/snmmi/"/>
    <link rel="related" href="https://nuclide.cc/technologies/radiopharmaceutical-gmp-release/"/>
    <link rel="related" href="https://nuclide.cc/technologies/radiopharmacy-network/"/>
    <id>https://nuclide.cc/calendar/#2027-02-04-snmmi-mid-winter-meeting-2027-san-francisco-4-to-6-february-</id>
    <updated>2027-02-04T00:00:00Z</updated>
    <summary type="text">Congress. The practice-side SNMMI meeting: radiopharmacy operations, dosimetry workshops, regulatory and coding sessions.</summary>
    <content type="html">&lt;p&gt;&lt;strong&gt;Congress&lt;/strong&gt;, confirmed.&lt;/p&gt;&lt;p&gt;The practice-side SNMMI meeting: radiopharmacy operations, dosimetry workshops, regulatory and coding sessions.&lt;/p&gt;&lt;p&gt;Related: &lt;a href=&quot;https://nuclide.cc/institutions/snmmi/&quot;&gt;Society of Nuclear Medicine and Molecular Imaging&lt;/a&gt;, &lt;a href=&quot;https://nuclide.cc/technologies/radiopharmaceutical-gmp-release/&quot;&gt;Radiopharmaceutical GMP and releasing a drug that decays&lt;/a&gt;, &lt;a href=&quot;https://nuclide.cc/technologies/radiopharmacy-network/&quot;&gt;Radiopharmacy and cyclotron networks&lt;/a&gt;&lt;/p&gt;&lt;p&gt;Source: &lt;a href=&quot;https://snmmi.org/AM/Web/Education-and-Meetings/Upcoming-Events.aspx&quot;&gt;https://snmmi.org/AM/Web/Education-and-Meetings/Upcoming-Events.aspx&lt;/a&gt;&lt;/p&gt;</content>
  </entry>
  <entry>
    <title>2027-02-11: ASCO Genitourinary Cancers Symposium 2027, San Francisco (11 to 13 February)</title>
    <link rel="alternate" href="https://nuclide.cc/calendar/"/>
    <link rel="related" href="https://www.asco.org/gu"/>
    <link rel="related" href="https://nuclide.cc/indications/prostate-mcrpc/"/>
    <link rel="related" href="https://nuclide.cc/indications/prostate-mhspc/"/>
    <link rel="related" href="https://nuclide.cc/drugs/pluvicto/"/>
    <link rel="related" href="https://nuclide.cc/drugs/lu177-psma-it/"/>
    <link rel="related" href="https://nuclide.cc/technologies/psma-pet/"/>
    <id>https://nuclide.cc/calendar/#2027-02-11-asco-genitourinary-cancers-symposium-2027-san-francisco-11-t</id>
    <updated>2027-02-11T00:00:00Z</updated>
    <summary type="text">Congress. Where PSMA radioligand therapy trials are first presented. The abstracts are deposited as Journal of Clinical Oncology supplements and are harvested by scripts/fetch-abstracts.ts.</summary>
    <content type="html">&lt;p&gt;&lt;strong&gt;Congress&lt;/strong&gt;, confirmed.&lt;/p&gt;&lt;p&gt;Where PSMA radioligand therapy trials are first presented. The abstracts are deposited as Journal of Clinical Oncology supplements and are harvested by scripts/fetch-abstracts.ts.&lt;/p&gt;&lt;p&gt;Related: &lt;a href=&quot;https://nuclide.cc/indications/prostate-mcrpc/&quot;&gt;Metastatic castration-resistant prostate cancer&lt;/a&gt;, &lt;a href=&quot;https://nuclide.cc/indications/prostate-mhspc/&quot;&gt;Metastatic hormone-sensitive prostate cancer&lt;/a&gt;, &lt;a href=&quot;https://nuclide.cc/drugs/pluvicto/&quot;&gt;Lutetium-177 vipivotide tetraxetan&lt;/a&gt;, &lt;a href=&quot;https://nuclide.cc/drugs/lu177-psma-it/&quot;&gt;177Lu-PSMA-I&amp;amp;T&lt;/a&gt;, &lt;a href=&quot;https://nuclide.cc/technologies/psma-pet/&quot;&gt;PSMA PET&lt;/a&gt;&lt;/p&gt;&lt;p&gt;Source: &lt;a href=&quot;https://www.asco.org/gu&quot;&gt;https://www.asco.org/gu&lt;/a&gt;&lt;/p&gt;</content>
  </entry>
  <entry>
    <title>2027-03-11: 9th Theranostics World Congress (TWC2027), Osaka (11 to 14 March)</title>
    <link rel="alternate" href="https://nuclide.cc/calendar/"/>
    <link rel="related" href="https://www.theranostics-world-congress.org/"/>
    <link rel="related" href="https://nuclide.cc/technologies/radioligand-therapy/"/>
    <link rel="related" href="https://nuclide.cc/drugs/ac225-psma/"/>
    <link rel="related" href="https://nuclide.cc/drugs/alphamedix/"/>
    <link rel="related" href="https://nuclide.cc/technologies/radioligand-dosimetry/"/>
    <id>https://nuclide.cc/calendar/#2027-03-11-9th-theranostics-world-congress-twc2027-osaka-11-to-14-march</id>
    <updated>2027-03-11T00:00:00Z</updated>
    <summary type="text">Congress. Theranostics-only congress with a dedicated targeted alpha therapy track; the 2027 edition is in Japan, which makes it the main meeting point for Asian alpha-emitter programmes.</summary>
    <content type="html">&lt;p&gt;&lt;strong&gt;Congress&lt;/strong&gt;, confirmed.&lt;/p&gt;&lt;p&gt;Theranostics-only congress with a dedicated targeted alpha therapy track; the 2027 edition is in Japan, which makes it the main meeting point for Asian alpha-emitter programmes.&lt;/p&gt;&lt;p&gt;Related: &lt;a href=&quot;https://nuclide.cc/technologies/radioligand-therapy/&quot;&gt;Radioligand therapy (beta emitters)&lt;/a&gt;, &lt;a href=&quot;https://nuclide.cc/drugs/ac225-psma/&quot;&gt;Actinium-225 PSMA agents&lt;/a&gt;, &lt;a href=&quot;https://nuclide.cc/drugs/alphamedix/&quot;&gt;212Pb-DOTAMTATE&lt;/a&gt;, &lt;a href=&quot;https://nuclide.cc/technologies/radioligand-dosimetry/&quot;&gt;Radioligand dosimetry&lt;/a&gt;&lt;/p&gt;&lt;p&gt;Source: &lt;a href=&quot;https://www.theranostics-world-congress.org/&quot;&gt;https://www.theranostics-world-congress.org/&lt;/a&gt;&lt;/p&gt;</content>
  </entry>
  <entry>
    <title>2027-04-30: 57th Annual Scientific Meeting of the Australian and New Zealand Society of Nuclear Medicine, Gold Coast (30 April to 2 May)</title>
    <link rel="alternate" href="https://nuclide.cc/calendar/"/>
    <link rel="related" href="https://www.anzsnm.org.au/news-events/2027-annual-scientific-meeting/"/>
    <link rel="related" href="https://nuclide.cc/companies/ansto/"/>
    <link rel="related" href="https://nuclide.cc/companies/clarity-pharmaceuticals/"/>
    <link rel="related" href="https://nuclide.cc/companies/telix/"/>
    <id>https://nuclide.cc/calendar/#2027-04-30-57th-annual-scientific-meeting-of-the-australian-and-new-zea</id>
    <updated>2027-04-30T00:00:00Z</updated>
    <summary type="text">Congress. Australia and New Zealand's nuclear medicine meeting. Australian developers (Telix, Clarity) and ANSTO's isotope supply report here.</summary>
    <content type="html">&lt;p&gt;&lt;strong&gt;Congress&lt;/strong&gt;, confirmed.&lt;/p&gt;&lt;p&gt;Australia and New Zealand's nuclear medicine meeting. Australian developers (Telix, Clarity) and ANSTO's isotope supply report here.&lt;/p&gt;&lt;p&gt;Related: &lt;a href=&quot;https://nuclide.cc/companies/ansto/&quot;&gt;ANSTO (Australian Nuclear Science and Technology Organisation)&lt;/a&gt;, &lt;a href=&quot;https://nuclide.cc/companies/clarity-pharmaceuticals/&quot;&gt;Clarity Pharmaceuticals&lt;/a&gt;, &lt;a href=&quot;https://nuclide.cc/companies/telix/&quot;&gt;Telix Pharmaceuticals&lt;/a&gt;&lt;/p&gt;&lt;p&gt;Source: &lt;a href=&quot;https://www.anzsnm.org.au/news-events/2027-annual-scientific-meeting/&quot;&gt;https://www.anzsnm.org.au/news-events/2027-annual-scientific-meeting/&lt;/a&gt;&lt;/p&gt;</content>
  </entry>
  <entry>
    <title>2027-06-05: SNMMI Annual Meeting 2027, Washington, DC (5 to 8 June)</title>
    <link rel="alternate" href="https://nuclide.cc/calendar/"/>
    <link rel="related" href="https://snmmi.org/AM/Web/Education-and-Meetings/Upcoming-Events.aspx"/>
    <link rel="related" href="https://nuclide.cc/institutions/snmmi/"/>
    <link rel="related" href="https://nuclide.cc/technologies/radioligand-therapy/"/>
    <link rel="related" href="https://nuclide.cc/technologies/psma-pet/"/>
    <link rel="related" href="https://nuclide.cc/technologies/prrt/"/>
    <id>https://nuclide.cc/calendar/#2027-06-05-snmmi-annual-meeting-2027-washington-dc-5-to-8-june-</id>
    <updated>2027-06-05T00:00:00Z</updated>
    <summary type="text">Congress. The largest nuclear medicine meeting in the United States: new tracers, radiochemistry, dosimetry and the year's radioligand trial updates across oncology, cardiology and neurology.</summary>
    <content type="html">&lt;p&gt;&lt;strong&gt;Congress&lt;/strong&gt;, confirmed.&lt;/p&gt;&lt;p&gt;The largest nuclear medicine meeting in the United States: new tracers, radiochemistry, dosimetry and the year's radioligand trial updates across oncology, cardiology and neurology.&lt;/p&gt;&lt;p&gt;Related: &lt;a href=&quot;https://nuclide.cc/institutions/snmmi/&quot;&gt;Society of Nuclear Medicine and Molecular Imaging&lt;/a&gt;, &lt;a href=&quot;https://nuclide.cc/technologies/radioligand-therapy/&quot;&gt;Radioligand therapy (beta emitters)&lt;/a&gt;, &lt;a href=&quot;https://nuclide.cc/technologies/psma-pet/&quot;&gt;PSMA PET&lt;/a&gt;, &lt;a href=&quot;https://nuclide.cc/technologies/prrt/&quot;&gt;Peptide receptor radionuclide therapy (PRRT)&lt;/a&gt;&lt;/p&gt;&lt;p&gt;Source: &lt;a href=&quot;https://snmmi.org/AM/Web/Education-and-Meetings/Upcoming-Events.aspx&quot;&gt;https://snmmi.org/AM/Web/Education-and-Meetings/Upcoming-Events.aspx&lt;/a&gt;&lt;/p&gt;</content>
  </entry>
  <entry>
    <title>2027-11-11: 67th Annual Scientific Meeting of the Japanese Society of Nuclear Medicine, Omiya (11 to 13 November)</title>
    <link rel="alternate" href="https://nuclide.cc/calendar/"/>
    <link rel="related" href="https://jsnm.org/english/meetings_and_events/"/>
    <link rel="related" href="https://nuclide.cc/institutions/jsnm/"/>
    <id>https://nuclide.cc/calendar/#2027-11-11-67th-annual-scientific-meeting-of-the-japanese-society-of-nu</id>
    <updated>2027-11-11T00:00:00Z</updated>
    <summary type="text">Congress. The 2027 edition of Japan's national nuclear medicine meeting, announced on the society's English meetings page.</summary>
    <content type="html">&lt;p&gt;&lt;strong&gt;Congress&lt;/strong&gt;, confirmed.&lt;/p&gt;&lt;p&gt;The 2027 edition of Japan's national nuclear medicine meeting, announced on the society's English meetings page.&lt;/p&gt;&lt;p&gt;Related: &lt;a href=&quot;https://nuclide.cc/institutions/jsnm/&quot;&gt;Japanese Society of Nuclear Medicine&lt;/a&gt;&lt;/p&gt;&lt;p&gt;Source: &lt;a href=&quot;https://jsnm.org/english/meetings_and_events/&quot;&gt;https://jsnm.org/english/meetings_and_events/&lt;/a&gt;&lt;/p&gt;</content>
  </entry>
</feed>
